Meditech CEO leaves, chair steps down

By Melissa Trudinger
Friday, 30 July, 2004

Meditech (ASX: MTR) is looking for a new CEO as CEO Chris Carter steps down, three months after a shareholder stoush forced his resignation from the company.

The problems arose at Meditech's AGM in late April, where Carter was due to stand for re-election to the board of directors. Slightly more than half of the proxy votes lodged, which represented about 12 per cent of all shareholders, voted against re-election, forcing Carter to withdraw his nomination and hand in his notice of resignation.

The stoush has also resulted in Bob Moses stepping down from his position as chairman of Meditech's board of directors, although he will remain a non-executive director for the time being. Richard Fox, former chairman of the company and a current director will take over as interim chairman.

According to a recent shareholder update from Moses, candidates for CEO are being interviewed at present, and a decision is likely to be announced shortly.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd